Health ❯ Healthcare ❯ Patient Safety

Medication Management

Recall Procedures Adverse Effects Patient Guidance Withdrawal Effects Consultation Practices Therapeutic Alternatives Prescription Tracking Corticosteroid Therapy Drug Replacement Time-Critical Medications Adverse Reactions Cancer Treatment Antibiotic Misuse Essential Medicines Guidance Antihistamine Prescribing Practices Consultation with Specialists Monitoring Drug Combinations CBD Consumption Effects Prescription Drugs Antibiotics Parkinson's Disease Treatment Recommendations Chemotherapy Antibiotic Stewardship Prescription Practices Pharmacy Services Dehydration Risks Drug Disposal Discontinuation Risks Community Engagement Anticoagulation Therapy Controlled Substances Traceability Issues Safeguarding Medication Errors Contamination Consultation with Physicians Consulting Healthcare Providers Responsible Use of Medications Professional Guidance Drug Expiration Stock Availability

JAMA Study Finds 1 in 4 Medicare Patients With Dementia Receive Risky CNS-Active Drugs

A JAMA analysis finds most of these prescriptions in 2021 lacked a documented clinical reason.

FDA Class II Recall Targets Generic Vyvanse After Dissolution Failures

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures